- Home
- SINT vs ADXN Comparison
SINT vs ADXN Comparison
Compare SINT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SINT
- ADXN
- Stock Information
- Founded
- SINT 1996
- ADXN 2002
- Country
- SINT United States
- ADXN Switzerland
- Employees
- SINT 20
- ADXN N/A
- Industry
- SINT Medical/Dental Instruments
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- SINT Health Care
- ADXN Health Care
- Exchange
- SINT Nasdaq
- ADXN Nasdaq
- Market Cap
- SINT 8.3M
- ADXN 8.0M
- IPO Year
- SINT 2014
- ADXN N/A
- Fundamental
- Price
- SINT $3.04
- ADXN $7.94
- Analyst Decision
- SINT Strong Buy
- ADXN Strong Buy
- Analyst Count
- SINT 1
- ADXN 1
- Target Price
- SINT $28.00
- ADXN $30.00
- AVG Volume (30 Days)
- SINT 65.3K
- ADXN 1.5K
- Earning Date
- SINT 08-14-2025
- ADXN 09-01-2025
- Dividend Yield
- SINT N/A
- ADXN N/A
- EPS Growth
- SINT N/A
- ADXN N/A
- EPS
- SINT N/A
- ADXN 0.10
- Revenue
- SINT $1,861,000.00
- ADXN $278,508.00
- Revenue This Year
- SINT N/A
- ADXN $86.57
- Revenue Next Year
- SINT $87.50
- ADXN N/A
- P/E Ratio
- SINT N/A
- ADXN $0.67
- Revenue Growth
- SINT N/A
- ADXN N/A
- 52 Week Low
- SINT $1.71
- ADXN $6.51
- 52 Week High
- SINT $8.60
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- SINT 58.68
- ADXN 45.33
- Support Level
- SINT $2.85
- ADXN $7.52
- Resistance Level
- SINT $3.13
- ADXN $8.21
- Average True Range (ATR)
- SINT 0.19
- ADXN 0.10
- MACD
- SINT 0.06
- ADXN -0.03
- Stochastic Oscillator
- SINT 89.02
- ADXN 50.00
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.